Wilson Sonsini Goodrich & Rosati has advised 4E Therapeutics. 4E Therapeutics, an Austin-based neuroscience company, has announced its acquisition by Eli Lilly and Company (NYSE: LLY)....
Wilson Sonsini Goodrich & Rosati has advised 4E Therapeutics. 4E Therapeutics, an Austin-based neuroscience company, has announced its acquisition by Eli Lilly and Company (NYSE: LLY)....
